Research

Antibody/Immunotherapy

 
 

Antibody/Immunotherapy

Cascadian Therapeutics is collaborating with Adimab for the discovery of novel antibodies against undisclosed immunotherapy targets in oncology. Cascadian Therapeutics is utilizing its internal expertise in immunotherapy to screen antibodies identified by Adimab against one or more selected targets. The program is at an early discovery phase.